241 related articles for article (PubMed ID: 30170821)
1. Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer.
Stokes SM; Wakeam E; Swords DS; Stringham JR; Varghese TK
Surgery; 2018 Dec; 164(6):1287-1293. PubMed ID: 30170821
[TBL] [Abstract][Full Text] [Related]
2. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
3. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
[TBL] [Abstract][Full Text] [Related]
4. Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance.
Maguire FB; Morris CR; Parikh-Patel A; Cress RD; Keegan THM; Li CS; Lin PS; Kizer KW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1059-1066. PubMed ID: 30842132
[TBL] [Abstract][Full Text] [Related]
5. Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer.
Groth SS; Al-Refaie WB; Zhong W; Vickers SM; Maddaus MA; D'Cunha J; Habermann EB
Ann Thorac Surg; 2013 Apr; 95(4):1221-6. PubMed ID: 23415239
[TBL] [Abstract][Full Text] [Related]
6. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.
Inverso G; Mahal BA; Aizer AA; Donoff RB; Chuang SK
J Oral Maxillofac Surg; 2016 Jun; 74(6):1241-7. PubMed ID: 26851312
[TBL] [Abstract][Full Text] [Related]
7. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
Fletcher SA; Cole AP; Lu C; Marchese M; Krimphove MJ; Friedlander DF; Mossanen M; Kilbridge KL; Kibel AS; Trinh QD
Cancer; 2020 Feb; 126(3):496-505. PubMed ID: 31626340
[TBL] [Abstract][Full Text] [Related]
8. Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery.
Rohlfing ML; Mays AC; Isom S; Waltonen JD
Laryngoscope; 2017 Dec; 127(12):2784-2789. PubMed ID: 28639701
[TBL] [Abstract][Full Text] [Related]
9. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
10. Changes in insurance status and emergency department visits after the 2008 economic downturn.
Watts SH; David Bryan E; Tarwater PM
Acad Emerg Med; 2015 Jan; 22(1):73-80. PubMed ID: 25545581
[TBL] [Abstract][Full Text] [Related]
11. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
12. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.
Virgo KS; Little AG; Fedewa SA; Chen AY; Flanders WD; Ward EM
J Am Coll Surg; 2011 Nov; 213(5):633-43. PubMed ID: 21907598
[TBL] [Abstract][Full Text] [Related]
13. Population-Level Differences in Rectal Cancer Survival in Uninsured Patients Are Partially Explained by Differences in Treatment.
Pulte D; Jansen L; Brenner H
Oncologist; 2017 Mar; 22(3):351-358. PubMed ID: 28220019
[TBL] [Abstract][Full Text] [Related]
14. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
Ayanian JZ; Kohler BA; Abe T; Epstein AM
N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
[TBL] [Abstract][Full Text] [Related]
15. Impact of payer status on survival in parotid malignancy.
Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
[TBL] [Abstract][Full Text] [Related]
16. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
17. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
[TBL] [Abstract][Full Text] [Related]
18. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
19. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
[TBL] [Abstract][Full Text] [Related]
20. The impact of health insurance status on the survival of patients with head and neck cancer.
Kwok J; Langevin SM; Argiris A; Grandis JR; Gooding WE; Taioli E
Cancer; 2010 Jan; 116(2):476-85. PubMed ID: 19937673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
